🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is conducted in Europe. The aim of this trial is to investigate ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2009-11
Trial ID
NCT01028404
Treatments Being Tested
This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Status
Terminated
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Start Date
2022-12-07
Trial ID
NCT04915404
Treatments Being Tested
This study will evaluate the safety and to characterize the systemic pharma...
Status
Completed
Location
Kimura Eye and Internal Medicine Hospital
Start Date
2017-11-28
Trial ID
NCT03335852
Treatments Being Tested
The purpose of the study is to evaluate the safety and tolerability of sing...
Status
Completed
Location
SGS Stuivenberg
Start Date
2009-12
Trial ID
NCT01023321
To assess the safety, tolerability and pharmacokinetics of ABT-199 in femal...
Status
Completed
Location
Site Reference ID/Investigator# 89694
Start Date
2012-11
Trial ID
NCT01686555
Compare the pharmacokinetic characteristics and safety between CKD-391 tabl...
Status
Completed
Location
INHA University Hospital
Start Date
2018-09-05
Trial ID
NCT03793985
The purpose of this clinical study is to compare 2 different versions cagri...
Status
Active Not Recruiting
Location
Celerion, Phoenix
Start Date
2026-05-20
Trial ID
NCT07605052
Treatments Being Tested
This study will evaluate the skin pharmacokinetics and tolerability of bima...
Status
Completed
Location
DermResearch, LLC
Start Date
2016-07
Trial ID
NCT02848300
Treatments Being Tested
Rhesus conflict between mother and fetus is due to the different antigenic ...
Status
Unknown
Location
Municipal non-profit enterprise "Cherkasy Regional Hospital of Cherkasy Regional Council"
Start Date
2022-02-08
Trial ID
NCT05245734
Treatments Being Tested